Frank McCaney Net Worth

The estimated Net Worth of Frank J Mccaney is at least $63.9 Thousand dollars as of 28 November 2016. Mr. Mccaney owns over 20,000 units of STRATA Skin Sciences Inc stock worth over $63,900 and over the last 8 years he sold SSKN stock worth over $0. In addition, he makes $0 as President and Director at STRATA Skin Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. McCaney SSKN stock SEC Form 4 insiders trading

Frank has made over 1 trades of the STRATA Skin Sciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of SSKN stock worth $10,200 on 28 November 2016.

The largest trade he's ever made was buying 20,000 units of STRATA Skin Sciences Inc stock on 28 November 2016 worth over $10,200. On average, Frank trades about 10,000 units every 0 days since 2016. As of 28 November 2016 he still owns at least 20,000 units of STRATA Skin Sciences Inc stock.

You can see the complete history of Mr. Mccaney stock trades at the bottom of the page.

Frank McCaney biography

Frank J. McCaney is President, Director of the Company. He is currently serving as President, Chief Executive Officer, Director of the Company. Mr. McCaney was most recently the chief executive officer of Corpak MedSystems, a private equity-backed medical device company in the field of enteral feeding. Corpak was sold to Halyard Health (HYH: NYSE) for $174 million in May 2016. Prior to Corpak, he was the founder and CEO of Nitric BioTherapeutics, a venture backed-medical technology company from 2006 until 2012. Prior to Nitric Bio, he was a senior executive at Viasys Healthcare, Inc. (VAS: NYSE), a medical technology company focusing on respiratory, neurology, medical disposable and orthopedic products and had a lead role in spinning Viasys out of Thermo Electron Corporation (TMO: NYSE). While at Viasys, Mr. McCaney had several responsibilities including strategy, business development and investor relations. He currently serves as a director of Diasome Pharmaceuticals, a privately-held company.

What's Frank McCaney's mailing address?

Frank's mailing address filed with the SEC is 100 Lakeside Dr #100, Horsham, PA 19044, USA.

Insiders trading at STRATA Skin Sciences Inc

Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ..., and Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.

What does STRATA Skin Sciences Inc do?

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.

Complete history of Mr. Mccaney stock trades at STRATA Skin Sciences Inc

STRATA Skin Sciences Inc executives and stock owners

STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include:

• Michael R. Stewart,
  Independent Consultant
• Kathryn Swintek,
  Independent Director
• David Stone,
  Independent Director
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Director
• James Coyne,
  Director
• Matthew Hill,
  Chief Financial Officer
• Dolev Rafaeli,
  Interim Chief Executive Officer
• Frank McCaney,
  President, Director
• LuAnn Via,
  Chairman of the Board
• Nikolai Kabelev,
  VP of R&D
• Shmuel Gov,
  Exec. VP & GM
• Dr. Darrell S. Rigel,
  Chief Medical Advisor
• Keith Simeone,
  VP of Sales
• Jay Sturm,
  Gen. Counsel & Corp. Sec.
• Christopher Lesovitz,
  Chief Financial Officer
• Robert J. Moccia,
  Pres, CEO & Director
• William D. Humphries,
  Exec. Chairman
• Healthcare Master Fund Ltd ...,
  
• Michael R Stewart,
  President & CEO
• Richard Rox Anderson,
  Director
• Christina L Allgeier,
  CFO
• David N Gill,
  
• Partners, L.P.Accelmed Part...,
  
• Douglas Strang,
  
• Samuel Rubinstein,
  
• Nachum Shamir,
  
• Christopher Lesovitz,
  Chief Financial Officer
• William D. Humphries,
  
• Uri Geiger,
  Director
• Wayne Cafran,
  
• Irit Yaniv,
  
• Patricia S Walker,
  
• Robert Joseph Moccia,
  Chief Executive Officer
• Lp22 Nw Fund, Lp22 Nw Fund ...,
  
• Shmuel Gov,
  COO